Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Equities
6990
CNE1000062J1
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.8 HKD | -4.02% |
|
-11.07% | +55.30% |
21/06 | Sichuan Kelun-Biotech Directors Approve Full Circulation of H-Shares | MT |
18/06 | Hong Kong Shares Fall on Weak Economic Data, Trade Tensions; Wuhan Youji Surges 27% in Trading Debut | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.30% | 4.75B | |
+16.13% | 122B | |
+19.65% | 115B | |
+21.22% | 26.64B | |
-23.84% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-19.28% | 15.49B | |
+63.81% | 14.83B | |
+1.94% | 13.67B |
- Stock Market
- Equities
- 6990 Stock
- News Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Kelun-Biotech Partners with Sichuan Hospital for R&D, Commercialization of Nuclear Therapy for Tumors; Shares Jump 6%